Thirty-day outcome of delayed versus early management of symptomatic carotid stenosis

Emilie Charmoille1, Vincenzo Brizzi2, Sandro Lepidi3

  • 1Vascular Surgery Department, Bordeaux University Hospital, Bordeaux, France; Bordeaux University, Bordeaux, France.

Insights

Early carotid endarterectomy (CEA) in symptomatic patients showed similar 30-day stroke and death rates compared to delayed CEA. This suggests that reducing the time to revascularization does not negatively impact patient outcomes.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiology

Background:

  • Symptomatic carotid stenosis poses a significant risk of stroke.
  • Timely intervention is crucial, but optimal timing for carotid endarterectomy (CEA) remains debated.

Purpose of the Study:

  • To compare the clinical outcomes of early (<15 days) versus delayed CEA in patients presenting with symptomatic carotid stenosis.
  • To evaluate the impact of symptom-to-surgery time on postoperative morbidity and mortality.

Main Methods:

  • Retrospective review of 149 patients undergoing CEA for symptomatic carotid stenosis (January 2006 - May 2010).
  • Patients were categorized into early (<15 days) and delayed (>15 days) surgery groups based on symptom onset.
  • Analysis of 30-day postoperative mortality, stroke, and myocardial infarction (MI) rates.

Main Results:

  • 149 patients were analyzed; 62 underwent early CEA and 87 underwent delayed CEA.
  • Thirty-day combined stroke and death rates were 1.7% for early CEA and 3.5% for delayed CEA.
  • Thirty-day combined stroke, death, and MI rates were 1.7% for early CEA and 5.9% for delayed CEA.

Conclusions:

  • Early CEA (<15 days) achieved 30-day mortality and morbidity rates equivalent to delayed CEA.
  • Adherence to carotid revascularization guidelines regarding symptom-to-knife time did not significantly impact outcomes in this cohort.
  • These findings support the safety and efficacy of early surgical intervention for symptomatic carotid stenosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
463
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
595